CYCA, APRE – Pump And Dump Alerts – February 6, 2012

| February 6, 2012 | 0 Comments

Pump and DumpWelcome to today’s Pump and Dump Alerts, where we will be exposing these two companies: Cytta (CYCA) and Aperture Health (APRE).

Here we identify a few of the “bogus” promotions going on in penny stocks today.

If you don’t know how these scams work, be sure to check out this free report that exposes the whole thing.  

Without further ado, here are today’s “disasters waiting to happen”:

Cytta (CYCA

Cytta is a development stage company focusing on the development of a remote medical monitoring model.  In this model, CYCA hopes to transmit medical data from a user’s home to an insurance company.  This data would include weight, blood glucose, and pulse.

Shares of this penny stock currently trade near $0.0016.

Actual Gains is hyping CYCA and they currently own 2 million shares.

Aperture Health (APRE)

Aperture Health is a healthcare information and services company. APRE primarily offers wellness360, which is a corporate health and wellness management program.  On November 16, 2011, Aperture Health terminated their SEC registration. 

Shares of APRE trade around $0.33.

Micro Stock Profits was paid $35,000 to pump shares of APRE.

A final word (and warning).

These are just a couple of the current inglorious “pump and dumps”.

Remember, there’s a lot more of this going on than we can highlight here.

For more in-depth coverage of penny stock pump and dumps, be sure to sign up for our free newsletter, Penny Stock Research

As you know, penny stocks are a great place to invest your money.  You just have to do your due diligence to stay away from all the scams out there these days!

Until next time,

Brian Walker

Tags: , , , ,

Category: Pump & Dump Alerts, Pump & Dump Daily

About the Author ()

Brian joins the Penny Stock Research team as a seasoned independent trader and financial analyst. Brian graduated with a B.S. from the University of North Florida and now resides in Scottsdale, Arizona. With a background in economics and statistics, he has a keen ability to uncover profitable and growth-focused companies. He has years of real life know-how in analyzing fundamental and technical data that gives him an edge drilling down on companies and financial results. With over 15 years trading experience, Brian has become an expert in the ever-changing equities markets. Today, he scours the markets hunting for penny stocks that offer low risk and high reward.